Anastrozole
Title: Anastrozole
CAS Registry Number: 120511-73-1
CAS Name: a,a,,-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
Additional Names: 2,2¢-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)
Manufacturers' Codes: ZD-1033; ICI-D-1033
Trademarks: Arimidex (AstraZeneca)
Molecular Formula: C17H19N5
Molecular Weight: 293.37
Percent Composition: C 69.60%, H 6.53%, N 23.87%
Literature References: Aromatase inhibitor. Prepn: P. N. Edwards, M. S. Large, EP 296749; eidem, US 4935437 (1989, 1990 both to ICI). Reviews of pharmacology, clinical pharmacokinetics: P. V. Plourde et al., Breast Cancer Res. Treat. 30, 103-111 (1994); idem et al., J. Steroid Biochem. Mol. Biol. 53, 175-179 (1995). Clinical trial in advanced breast cancer: A. U. Buzdar et al., Cancer 79, 730 (1997).
Properties: Crystals from ethyl acetate/cyclohexane, mp 81-82°.
Melting point: mp 81-82°
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic (Hormonal); Aromatase Inhibitors; Aromatase Inhibitors.

Others monographs:
Guanidinium Aluminum Sulfate HexahydrateChicleHeptanal Sodium BisulfiteTrimethaphan Camsylate
Kresoxim-methylSimazineSultroponiumNovobiocin
CyanopsinApyrasePotassium Chromate(VI)Ferric Hydroxide
KonjacDigoxigeninNystatinPetunidin
©2016 DrugLead US FDA&EMEA